Previous close | 68.43 |
Open | 68.43 |
Bid | 66.00 |
Ask | 71.00 |
Strike | 47.50 |
Expiry date | 2026-01-16 |
Day's range | 68.43 - 68.43 |
Contract range | N/A |
Volume | |
Open interest | 6 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.